The pharmaceutical tablet universally known by the imprint “M522” is a combination prescription medicine formulated to manage acute, moderate-to-severe pain. It brings together two distinctly different chemical compounds—an opioid and a non-opioid analgesic—to provide a multi-layered defense against pain signals in the body.
Because it contains a powerful, tightly regulated opioid component, understanding its exact physical profile, biochemical behavior, and strict safety guidelines is paramount.
Pill Identification
Accurate visual identification is an essential safety barrier against accidental medication errors and counterfeit black-market drugs.
Active Ingredients: Each authentic tablet contains a fixed-dose combination of 7.5 mg of Oxycodone Hydrochloride and 325 mg of Acetaminophen.
- Manufacturer: Mallinckrodt Pharmaceuticals, a major generic drug manufacturer in the United States.
- Visual Characteristics
- Color: White
- Shape: Oblong (frequently described as a capsule-shaped or oblong tablet)
- Imprint (Side A): Stamped with the letter “M” inside a distinct square box outline (the signature Mallinckrodt corporate logo).
- Imprint (Side B): Stamped with the number “522”. It features a clean, horizontal score line dividing the numbers, allowing the tablet to be cleanly split into two equal halves (each containing 3.75 mg of oxycodone and 162.5 mg of acetaminophen) if a doctor prescribes a lower dose.
Critical Fentanyl Counterfeit Warning: In the modern illicit drug landscape, fake prescription pills are highly prevalent. Cartels and underground labs use illicit industrial pill presses to stamp white binder powders containing lethal doses of fentanyl or synthetic nitazenes with fake “M” and “522” logos. If your pill was not obtained directly from a licensed, commercial pharmacy, or if the texture feels unusually chalky, crumbly, or unevenly stamped, treat it as an immediate, life-threatening hazard. —
Mechanism of Action (How It Works)
The M522 tablet functions through a dual-action synergistic mechanism. By combining oxycodone and acetaminophen, it attacks pain pathways simultaneously from two entirely different biochemical directions:
- Oxycodone Hydrochloride (The Central Nervous System Blockade): Oxycodone is a semi-synthetic Schedule II opioid agonist. Once it crosses the blood-brain barrier, it binds strongly to mu-opioid receptors scattered across the brain and spinal cord. When activated, these receptors inhibit the release of excitatory neurotransmitters that carry pain messages. This dramatically alters both the physical transmission of pain and the brain’s subjective, emotional perception of that pain. It also triggers a release of dopamine in the brain’s reward centers, causing a state of deep relaxation and potential euphoria.
- Acetaminophen (The Peripheral Blockade): Acetaminophen is a non-opioid, non-NSAID analgesic. While its exact mechanism is still being mapped, it works primarily by inhibiting cyclooxygenase (COX) enzymes in the central nervous system, reducing the production of pain-amplifying chemicals called prostaglandins. It also acts directly on the brain’s hypothalamic heat-regulating center to reduce fever.
By using both drugs together, the acetaminophen enhances the pain-relieving effects of the oxycodone. This allows the patient to get substantial pain relief using a lower total dose of the opioid than would otherwise be required, minimizing some opioid-specific side effects.
Standard Dosage and Administration
Dosage must be explicitly tailored by a licensed physician. It is typically reserved for acute, short-term pain relief (such as post-operative recovery, severe orthopedic trauma, or acute dental pain). \
- Standard Therapeutic Dosing: For adults who do not regularly take opioids (“opioid-naive”), the standard starting dose is 1 tablet every 6 hours as needed for pain.
- The 24-Hour Acetaminophen Safety Ceiling: Each M522 pill contains 325 mg of acetaminophen. To avoid irreversible, catastrophic liver damage, an adult’s total intake of acetaminophen from all sources (including over-the-counter cold medicines or sleep aids) must never exceed 4,000 mg (4 grams) in any 24-hour period. For this specific tablet, taking 12 pills in a day hits that limit. However, a doctor will generally establish a much tighter safety buffer, usually capping use at 4 to 6 tablets maximum per day.
- Administration: The pill can be taken with or without food. If a patient experiences a sudden wave of nausea upon taking it, swallowing the dose alongside a light meal or a glass of milk can help soothe the stomach lining.
Side Effects
The systemic impact of an opioid combination medicine can trigger various physiological side effects, ranging from predictable and mild to highly critical.
Common Side Effects (Manageable)
These are frequent side effects that occur as the central nervous system adjusts to the medication:
- Drowsiness, profound lethargy, or mental clouding
- Dizziness, lightheadedness, or a floating sensation
- Nausea, vomiting, and a dry mouth
- Opioid-Induced Constipation: Opioids paralyze the smooth muscle contractions of the gastrointestinal tract. Because the human body never builds a tolerance to this side effect, physicians almost always recommend taking a daily stool softener concurrently with an M522 regimen.
- Mild skin itching (pruritus) or facial flushing caused by a harmless histamine release.
Severe and Life-Threatening Side Effects (Requires Emergency Care)
- Respiratory Depression: Drastically slowed, shallow, or irregular breathing that leaves the body starved of oxygen.
- Severe Hypotension: An abrupt, severe drop in blood pressure that can cause fainting, circulatory collapse, or shock.
- Anaphylaxis: Rare but severe allergic reactions to acetaminophen or oxycodone, marked by hives, facial swelling, throat tightening, and difficulty breathing.
- Acute Hepatotoxicity: Severe liver injury characterized by yellowing of the skin or eyes (jaundice), intense upper-right abdominal pain, and dark urine.
Precautions and Pre-existing Conditions
Before an M522 regimen is initiated, a patient’s full medical history must be carefully screened against severe contraindications:
- Respiratory Disorders: This medicine is strictly contraindicated for individuals with severe asthma, significant Chronic Obstructive Pulmonary Disease (COPD), or pre-existing respiratory depression.
- Hepatic (Liver) Impairment: Because acetaminophen is heavily processed by the liver, anyone with a history of liver disease, cirrhosis, hepatitis, or severe alcoholism faces an elevated risk of acute liver failure.
- Gastrointestinal Blockages: It must not be given to patients with a known or suspected bowel obstruction, specifically paralytic ileus, as opioids further freeze intestinal motility.
- Pregnancy and NOWS: Chronic use of M522 during pregnancy can result in Neonatal Opioid Withdrawal Syndrome (NOWS). The newborn infant will experience physical opioid withdrawal immediately after birth, a life-threatening condition requiring specialized medical management in a neonatal intensive care unit (NICU).
Boxed Warnings (The Strictest FDA Protocols)
Due to the potent nature of its active ingredients, the FDA mandates strict Boxed Warnings on the prescribing documentation for oxycodone/acetaminophen combinations:
Addiction, Abuse, and Misuse
Oxycodone is a Schedule II controlled substance. Even when taken exactly as prescribed by a medical professional, it carries an inherent risk of physical dependence and psychological addiction. Misuse or abuse of this medication can easily lead to overdose and death.
Life-Threatening Respiratory Depression
Opioids depress the respiratory drive in the brainstem. Fatal respiratory depression can occur at normal therapeutic doses. This vulnerability is highest when first starting the M522 tablet or when a doctor increases the overall dosage strength.
Accidental Ingestion Hazard
A single accidental dose of an M522 tablet, particularly by a toddler or child, can result in a fatal oxycodone overdose. The medication must always be stored in a secure, out-of-reach location, preferably a locked medicine safe.
Fatal Drug Interactions (CNS Depressants)
Combining the M522 pill with other substances that slow down the brain and central nervous system can cause immediate sedation, respiratory arrest, coma, and death. Never mix this medication with
- Alcoholic beverages
- Benzodiazepines (e.g., Xanax, Valium, Ativan, Klonopin)
- Prescription sleep aids (e.g., Ambien, Lunesta)
- Skeletal muscle relaxants (e.g., Flexeril)
Acute Liver Failure The acetaminophen component carries an explicit warning regarding severe, acute hepatotoxicity. Patients must thoroughly check the labels of all concurrent medications to ensure they are not inadvertently taking double doses of acetaminophen.